<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">The Clinician</journal-id><journal-title-group><journal-title xml:lang="en">The Clinician</journal-title><trans-title-group xml:lang="ru"><trans-title>Клиницист</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1818-8338</issn><issn publication-format="electronic">2412-8775</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">22</article-id><article-id pub-id-type="doi">10.17650/1818-8338-2013-2-6-13</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>EDITORIAL</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>РЕДАКЦИОННАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">POSSIBLE ROLE OF MITOCHONDRIAL GENOME MUTATIONS IN CORONARY HEART DISEASE</article-title><trans-title-group xml:lang="ru"><trans-title>Возможная роль мутаций митохондриального генома при ишемической болезни сердца</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Egorova</surname><given-names>L. A.</given-names></name><name xml:lang="ru"><surname>Егорова</surname><given-names>Л. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ezhov</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Ежов</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>marat_ezhov@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shiganova</surname><given-names>G. M.</given-names></name><name xml:lang="ru"><surname>Шиганова</surname><given-names>Г. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Postnov</surname><given-names>A. Yu.</given-names></name><name xml:lang="ru"><surname>Постнов</surname><given-names>А. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian Cardiology Research-and-Production Complex, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ «Российский кардиологический научно-производственный комплекс» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">City Polyclinic Two, Moscow Healthcare Department</institution></aff><aff><institution xml:lang="ru">ГБУЗ «Городская поликлиника № 2» Департамента здравоохранения г. Москвы</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2013</year></pub-date><volume>7</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>6</fpage><lpage>13</lpage><history><date date-type="received" iso-8601-date="2014-07-14"><day>14</day><month>07</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-07-14"><day>14</day><month>07</month><year>2014</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2013, Egorova L.A., Ezhov M.V., Shiganova G.M., Postnov A.Y.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2013, Егорова Л.А., Ежов М.В., Шиганова Г.М., Постнов А.Ю.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="en">Egorova L.A., Ezhov M.V., Shiganova G.M., Postnov A.Y.</copyright-holder><copyright-holder xml:lang="ru">Егорова Л.А., Ежов М.В., Шиганова Г.М., Постнов А.Ю.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://klinitsist.abvpress.ru/Klin/article/view/22">https://klinitsist.abvpress.ru/Klin/article/view/22</self-uri><abstract xml:lang="en"><p>Mitochondria are not only the major producers of adenosine triphosphate, but also an endogenous source of reactive oxygen species. Mitochondrialdysfunction plays a key role in the trigger and progression of atherosclerotic lesion. Impaired function in the mitochondria due to their elevated level of oxidized oxygen species, the accumulation of mitochondrial DNA damages, and the exhaustion of respiratory chains induces dysfunction and apoptosis in the endothelial cells; activation of matrix metalloproteinases; growth of vascular smooth muscle cells and their migration into the intima; expression of adhesion molecules, and oxidation of low-density lipoproteins. Mitochondrial dysfunction may be an important unifying mechanism that accounts for the atherogenic effect of major cardiovascular risk factors. Small clinical pilot studies have shown an association of different mitochondrial genome mutations with atherosclerotic lesion in the artery. Taking into account the available data on the possible role of mitochondria in atherogenesis, novel drugs are now being designed to affect mitochondrial function.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>mitochondrial genome</kwd><kwd>mutations</kwd><kwd>coronary heart disease</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>митохондриальный геном</kwd><kwd>мутации</kwd><kwd>ишемическая болезнь сердца</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Sobenin I.A., Sazonova M.A., Ivanova M.M. et al. Mutation C3256T of mitochondrial genome in white blood cells: novel genetic marker of atherosclerosis and coronary heart disease. PLoS One 2012;7(10):46573.</mixed-citation><mixed-citation xml:lang="ru">Sobenin I.A., Sazonova M.A., Ivanova M.M. et al. Mutation C3256T of mitochondrial genome in white blood cells: novel genetic marker of atherosclerosis and coronary heart disease. PLoS One 2012;7(10):46573.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Anderson S., Bankier A.T., Barrell B.G. et al. Sequence and organization of the human mitochondrial genome. Nature 1981;290(5806):457–65.</mixed-citation><mixed-citation xml:lang="ru">Anderson S., Bankier A.T., Barrell B.G. et al. Sequence and organization of the human mitochondrial genome. Nature 1981;290(5806):457–65.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Camara A.K., Lesnefsky E.J., Stowe D.F. Potential therapeutic benefits of stretegies directed to mitochondria. Antioxid Redox Signal 2010;13(3):279–347.</mixed-citation><mixed-citation xml:lang="ru">Camara A.K., Lesnefsky E.J., Stowe D.F. Potential therapeutic benefits of stretegies directed to mitochondria. Antioxid Redox Signal 2010;13(3):279–347.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Lenka N., Vijayasarathy C., Mullick J., Avadhani N.G. Structural organization and transcription regulation of nuclear genes encoding the mammalian cytochrome c oxidase complex. Prog Nucleic Acid Res Mol Biol 1998;61:309–44.</mixed-citation><mixed-citation xml:lang="ru">Lenka N., Vijayasarathy C., Mullick J., Avadhani N.G. Structural organization and transcription regulation of nuclear genes encoding the mammalian cytochrome c oxidase complex. Prog Nucleic Acid Res Mol Biol 1998;61:309–44.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Ballinger S.W., Petterson C., Yan C.N. et al. Hydrogen peroxide- and peroxynitriteinduced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res 2000;86(9):960–6.</mixed-citation><mixed-citation xml:lang="ru">Ballinger S.W., Petterson C., Yan C.N. et al. Hydrogen peroxide- and peroxynitriteinduced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ Res 2000;86(9):960–6.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Тодоров И.Н., Тодоров Г.И. Мультифакторная природа высокой частоты мутаций в мтДНК cоматических клеток млекопитающих. Биохимия 2009;74(9):1184–94.</mixed-citation><mixed-citation xml:lang="ru">Тодоров И.Н., Тодоров Г.И. Мультифакторная природа высокой частоты мутаций в мтДНК cоматических клеток млекопитающих. Биохимия 2009;74(9):1184–94.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Wallace D.C., Ye J.H., Neckelmann S.N. et al. Sequence analysis of cDNAs for the human and bovine ETP synthase beta subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr Genet 1987;12(2):81–90.</mixed-citation><mixed-citation xml:lang="ru">Wallace D.C., Ye J.H., Neckelmann S.N. et al. Sequence analysis of cDNAs for the human and bovine ETP synthase beta subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr Genet 1987;12(2):81–90.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Kmiec B., Woloszynska M., Janska H. Heteroplasmy as a common state of mitochondrial genetic information in plants and animals. Curr Genet 2006;50(3):149–59.</mixed-citation><mixed-citation xml:lang="ru">Kmiec B., Woloszynska M., Janska H. Heteroplasmy as a common state of mitochondrial genetic information in plants and animals. Curr Genet 2006;50(3):149–59.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Wonnapinij P., Chinnery P.F., Samuels D.C. The distribution of mitochondrial DNA heteroplasmy due to random genetic drift. Am J Hum Genet 2008;83(5):582–93.</mixed-citation><mixed-citation xml:lang="ru">Wonnapinij P., Chinnery P.F., Samuels D.C. The distribution of mitochondrial DNA heteroplasmy due to random genetic drift. Am J Hum Genet 2008;83(5):582–93.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Lightowlers R.N., Chinnery P.F., Turnbull D.M., Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet 1997;13(11):450–5.</mixed-citation><mixed-citation xml:lang="ru">Lightowlers R.N., Chinnery P.F., Turnbull D.M., Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet 1997;13(11):450–5.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. van Blerkom J. Mitochondria as regulatory forces in oocytes, preimplantation embryos and stem cells. Reprod Biomed Online 2008;16(4):553–69.</mixed-citation><mixed-citation xml:lang="ru">van Blerkom J. Mitochondria as regulatory forces in oocytes, preimplantation embryos and stem cells. Reprod Biomed Online 2008;16(4):553–69.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Cree L.M., Samuels D.C., de Sousa Lopes S.C. et al. A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes. Net. Genet 2008;40(2):249–54.</mixed-citation><mixed-citation xml:lang="ru">Cree L.M., Samuels D.C., de Sousa Lopes S.C. et al. A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes. Net. Genet 2008;40(2):249–54.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Lenaz G., Genova M.L. Structure and organization of mitochondrial respiratory complexes: a new understanding of an old subject. Antioxid Redox Signal 2010;12(8):961–1008.</mixed-citation><mixed-citation xml:lang="ru">Lenaz G., Genova M.L. Structure and organization of mitochondrial respiratory complexes: a new understanding of an old subject. Antioxid Redox Signal 2010;12(8):961–1008.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Waldmeier P.C. Prospects for antiapoptotic drug therapy of neurodegenerative diseases. Prog</mixed-citation><mixed-citation xml:lang="ru">Waldmeier P.C. Prospects for antiapoptotic drug therapy of neurodegenerative diseases. Prog</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><mixed-citation>Neuropsychopharmacol Biol Psychiatry 2003;27(2):303–21.</mixed-citation></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">15. Fernandez-Moreno M.A., Bornstein В., Petit N., Garesse R. The pathophysiology of mitochondrial</mixed-citation><mixed-citation xml:lang="ru">Fernandez-Moreno M.A., Bornstein В., Petit N., Garesse R. The pathophysiology of mitochondrial</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><mixed-citation>biogenesis: towards four decades of mitochondrial DNA research. Mol Genet Metab 2000;71(3):481–95.</mixed-citation></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">16. Dimauro S. Mitochondrial medicine. Biochim Biophys Acta 2004;1659 (2–3):107–14.</mixed-citation><mixed-citation xml:lang="ru">Dimauro S. Mitochondrial medicine. Biochim Biophys Acta 2004;1659 (2–3):107–14.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">17. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000;87(3):179–83.</mixed-citation><mixed-citation xml:lang="ru">Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000;87(3):179–83.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">18. Dedkova E.N., Ji X., Lipsius S.L., Blatter L.A. Mitochondrial calcium uptake stimulates nitric oxide production in mitochondria of bovine vascular endothelial cells. Am J Physiol 2004;286(2):C406–15.</mixed-citation><mixed-citation xml:lang="ru">Dedkova E.N., Ji X., Lipsius S.L., Blatter L.A. Mitochondrial calcium uptake stimulates nitric oxide production in mitochondria of bovine vascular endothelial cells. Am J Physiol 2004;286(2):C406–15.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">19. Poteser M., Graziani A., Rosker C. et al. TRPC3 and TRPC4 associate to form a redox-sensitive cation channel. Evidence for expression of native TRPC3–TRPC4 heteromeric channels in endothelial cells. J Biol Chem 2006: 281(19):13588–95.</mixed-citation><mixed-citation xml:lang="ru">Poteser M., Graziani A., Rosker C. et al. TRPC3 and TRPC4 associate to form a redox-sensitive cation channel. Evidence for expression of native TRPC3–TRPC4 heteromeric channels in endothelial cells. J Biol Chem 2006: 281(19):13588–95.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">20. Spitaler M.M., Graier W.F. Vascular targets of redox signaling in diabetes mellitus. Diabetologia 2002;45(4):476–94.</mixed-citation><mixed-citation xml:lang="ru">Spitaler M.M., Graier W.F. Vascular targets of redox signaling in diabetes mellitus. Diabetologia 2002;45(4):476–94.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">21. Knight-Lozano C.A., Young C.G., Burow D.L. et al. Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 2002;105(7):849–54.</mixed-citation><mixed-citation xml:lang="ru">Knight-Lozano C.A., Young C.G., Burow D.L. et al. Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 2002;105(7):849–54.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">22. Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002;51(10):2944–50.</mixed-citation><mixed-citation xml:lang="ru">Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002;51(10):2944–50.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">23. Madamanchi N.R., Runge M.S. Mitochondrial dysfunction in atherosclerosis. Circ Res 2007;100(4):460–73.</mixed-citation><mixed-citation xml:lang="ru">Madamanchi N.R., Runge M.S. Mitochondrial dysfunction in atherosclerosis. Circ Res 2007;100(4):460–73.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">24. Puddu P., Puddu G.M., Galletti L. et al. Mitochondrial dysfunction as an initiating event in atherogenesis: а plausible hypothesis. Cardiology 2005;103(3):137–41.</mixed-citation><mixed-citation xml:lang="ru">Puddu P., Puddu G.M., Galletti L. et al. Mitochondrial dysfunction as an initiating event in atherogenesis: а plausible hypothesis. Cardiology 2005;103(3):137–41.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">25. Dai Y.L., Luk T.H., Siu C.W. et al. Mitochondrial dysfunction induced by statin contributes to endothelial dysfunction in patients with coronary artery disease. Cardiovasc Toxicol 2010;10(2):130–8.</mixed-citation><mixed-citation xml:lang="ru">Dai Y.L., Luk T.H., Siu C.W. et al. Mitochondrial dysfunction induced by statin contributes to endothelial dysfunction in patients with coronary artery disease. Cardiovasc Toxicol 2010;10(2):130–8.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">26. Vaux D.L. Apoptogenic factors released from mitochondria. Biochim Biophys Acta 2011;1813(4):546–50.</mixed-citation><mixed-citation xml:lang="ru">Vaux D.L. Apoptogenic factors released from mitochondria. Biochim Biophys Acta 2011;1813(4):546–50.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">27. Vindis C., Elbaz M., Escargueil-Blanc I. et al. Two distinct calcium-dependent mitochondrial pathways are involved in oxidized LDL-induced apoptosis. Arterioscler Thromb Vasc Biol 2005:25(3):639–45.</mixed-citation><mixed-citation xml:lang="ru">Vindis C., Elbaz M., Escargueil-Blanc I. et al. Two distinct calcium-dependent mitochondrial pathways are involved in oxidized LDL-induced apoptosis. Arterioscler Thromb Vasc Biol 2005:25(3):639–45.</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">28. Gorenne I., Kavurma M., Scott S., Bennett M. Vascular smooth muscle cell senescence in atherosclerosis. Cardiovasc Res 2006;72(1):9–17.</mixed-citation><mixed-citation xml:lang="ru">Gorenne I., Kavurma M., Scott S., Bennett M. Vascular smooth muscle cell senescence in atherosclerosis. Cardiovasc Res 2006;72(1):9–17.</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">29. Nakamura N., Hattori N., Tanaka M., Mizuno Y. Specific detection of deleted mitochondrial DNA by in situ hybridization using a chimera probe. Biochim Biophys Acta 1996;1308(3):215–21.</mixed-citation><mixed-citation xml:lang="ru">Nakamura N., Hattori N., Tanaka M., Mizuno Y. Specific detection of deleted mitochondrial DNA by in situ hybridization using a chimera probe. Biochim Biophys Acta 1996;1308(3):215–21.</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">30. Botto N., Rizza A., Colombo M.G. et al. Evidence for DNA damage in patients with coronary artery disease. Mutat Res 2001;493(1–2):23–30.</mixed-citation><mixed-citation xml:lang="ru">Botto N., Rizza A., Colombo M.G. et al. Evidence for DNA damage in patients with coronary artery disease. Mutat Res 2001;493(1–2):23–30.</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">31. Martinet W., Knaapen M.W., De Meyer G.R. et al. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002;20;106(8):927–32.</mixed-citation><mixed-citation xml:lang="ru">Martinet W., Knaapen M.W., De Meyer G.R. et al. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002;20;106(8):927–32.</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">32. Ballinger S.W., Patterson C., Knight Lozano C.A. et al. Mitochondrial integrity and function in atherogenesis. Circulation 2002;106(5):544–9.</mixed-citation><mixed-citation xml:lang="ru">Ballinger S.W., Patterson C., Knight Lozano C.A. et al. Mitochondrial integrity and function in atherogenesis. Circulation 2002;106(5):544–9.</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">33. Ballinger S.W. Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 2005;38(10):1278–95.</mixed-citation><mixed-citation xml:lang="ru">Ballinger S.W. Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med 2005;38(10):1278–95.</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">34. Harrison D., Griendling K.K., Landmesser U. et al. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003;91(3A):7A–11A.</mixed-citation><mixed-citation xml:lang="ru">Harrison D., Griendling K.K., Landmesser U. et al. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003;91(3A):7A–11A.</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">35. Fearon I.M., Faux S.P. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol 2009;47(3):372–81.</mixed-citation><mixed-citation xml:lang="ru">Fearon I.M., Faux S.P. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol 2009;47(3):372–81.</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">36. Yao P.M., Tabas I. Free cholesterol loading of macrophages is associeted with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J Biol Chem 2001;276(45):42468–76.</mixed-citation><mixed-citation xml:lang="ru">Yao P.M., Tabas I. Free cholesterol loading of macrophages is associeted with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J Biol Chem 2001;276(45):42468–76.</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">37. Raha S., Robinson B.H. Mitochondria, oxygen free radicals, and apoptosis. Am J Med Genet 2001;106(1):62–70.</mixed-citation><mixed-citation xml:lang="ru">Raha S., Robinson B.H. Mitochondria, oxygen free radicals, and apoptosis. Am J Med Genet 2001;106(1):62–70.</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">38. Fleming I., Mohamed A., Galle J. et al. Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCalpha. Cardiovasc Res 2005;65(4):897–906.</mixed-citation><mixed-citation xml:lang="ru">Fleming I., Mohamed A., Galle J. et al. Oxidized low-density lipoprotein increases superoxide production by endothelial nitric oxide synthase by inhibiting PKCalpha. Cardiovasc Res 2005;65(4):897–906.</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">39. Geng Y.J., Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol 2002;22(9):1370–80.</mixed-citation><mixed-citation xml:lang="ru">Geng Y.J., Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol 2002;22(9):1370–80.</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">40. Ward N.C., Croft K.D. Hypertension and oxidative stress. Clin Exp Pharmacol Physiol 2006;33(9):872–6.</mixed-citation><mixed-citation xml:lang="ru">Ward N.C., Croft K.D. Hypertension and oxidative stress. Clin Exp Pharmacol Physiol 2006;33(9):872–6.</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">41. Postnov Iu.V. The role of mitochondrial calcium overload and energy deficiency in pathogenesis of arterial hypertension. Arkh Patol 2001;63(3):3–10.</mixed-citation><mixed-citation xml:lang="ru">Postnov Iu.V. The role of mitochondrial calcium overload and energy deficiency in pathogenesis of arterial hypertension. Arkh Patol 2001;63(3):3–10.</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">42. Miró O., Alonso J.R., Jarreta D.et al. Smoking disturbs mitochondrial respiratory chain function and enhances lipid peroxidation on human circulating lymphocytes. Carcinogenesis 1999;20(7):1331–6.</mixed-citation><mixed-citation xml:lang="ru">Miró O., Alonso J.R., Jarreta D.et al. Smoking disturbs mitochondrial respiratory chain function and enhances lipid peroxidation on human circulating lymphocytes. Carcinogenesis 1999;20(7):1331–6.</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><citation-alternatives><mixed-citation xml:lang="en">43. Andreassi M.G., Botto N., Colombo M.G. et al. Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular diseases? Environ Mol Mutagen 2000;35(4):265–9.</mixed-citation><mixed-citation xml:lang="ru">Andreassi M.G., Botto N., Colombo M.G. et al. Genetic instability and atherosclerosis: can somatic mutations account for the development of cardiovascular diseases? Environ Mol Mutagen 2000;35(4):265–9.</mixed-citation></citation-alternatives></ref><ref id="B46"><label>46.</label><citation-alternatives><mixed-citation xml:lang="en">44. Pohjoismäki J.L., Goffart S., Taylor R.W. et al. Developmental and pathological changes in the human cardiac muscle mitochondrial DNA organization, replication and copy number. PLoS One 2010;5(5):e10426.</mixed-citation><mixed-citation xml:lang="ru">Pohjoismäki J.L., Goffart S., Taylor R.W. et al. Developmental and pathological changes in the human cardiac muscle mitochondrial DNA organization, replication and copy number. PLoS One 2010;5(5):e10426.</mixed-citation></citation-alternatives></ref><ref id="B47"><label>47.</label><citation-alternatives><mixed-citation xml:lang="en">45. Rorbach J., Yusoff A.A., Tuppen H. et al. Overexpression of human mitochondrial valyl tRNA synthetase can partially restore levels of cognate mt-tRNAVal carrying the pathogenic C25U mutation. Nucleic Acids Res 2008;36(9):3065–74.</mixed-citation><mixed-citation xml:lang="ru">Rorbach J., Yusoff A.A., Tuppen H. et al. Overexpression of human mitochondrial valyl tRNA synthetase can partially restore levels of cognate mt-tRNAVal carrying the pathogenic C25U mutation. Nucleic Acids Res 2008;36(9):3065–74.</mixed-citation></citation-alternatives></ref><ref id="B48"><label>48.</label><citation-alternatives><mixed-citation xml:lang="en">46. Bornstein B., Mas J.A., Patrono C. et al. Comparative analysis of the pathogenic mechanisms associated with the G8363A and A8296G mutations in the mitochondrial tRNA(Lys) gene. Biochem J 2005;387(Pt3):773–8.</mixed-citation><mixed-citation xml:lang="ru">Bornstein B., Mas J.A., Patrono C. et al. Comparative analysis of the pathogenic mechanisms associated with the G8363A and A8296G mutations in the mitochondrial tRNA(Lys) gene. Biochem J 2005;387(Pt3):773–8.</mixed-citation></citation-alternatives></ref><ref id="B49"><label>49.</label><citation-alternatives><mixed-citation xml:lang="en">47. Raha S., Merante F., Shoubridge E. et al. Repopulation of rho0 cells with mitochondria from a patient with a mitochondrial DNA point mutation in tRNA(Gly) results in respiratory chain dysfunction. Hum Mutat 1999;13(3):245–54.</mixed-citation><mixed-citation xml:lang="ru">Raha S., Merante F., Shoubridge E. et al. Repopulation of rho0 cells with mitochondria from a patient with a mitochondrial DNA point mutation in tRNA(Gly) results in respiratory chain dysfunction. Hum Mutat 1999;13(3):245–54.</mixed-citation></citation-alternatives></ref><ref id="B50"><label>50.</label><citation-alternatives><mixed-citation xml:lang="en">48. Mimaki M., Ikota A., Seto A. et al. A double mutation (G11778A and G12192A) in mitochondrial DNA associated with Leber's hereditary optic neuropathy and cardiomyopathy. J Hum Genet 2003;48(1):47–50.</mixed-citation><mixed-citation xml:lang="ru">Mimaki M., Ikota A., Seto A. et al. A double mutation (G11778A and G12192A) in mitochondrial DNA associated with Leber's hereditary optic neuropathy and cardiomyopathy. J Hum Genet 2003;48(1):47–50.</mixed-citation></citation-alternatives></ref><ref id="B51"><label>51.</label><citation-alternatives><mixed-citation xml:lang="en">49. Chol M., Lebon S., Bénit P. et al. The mitochondrial DNA G13513A MELAS mutetion in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiency. J Med Genet 2003;40(3):188–91.</mixed-citation><mixed-citation xml:lang="ru">Chol M., Lebon S., Bénit P. et al. The mitochondrial DNA G13513A MELAS mutetion in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiency. J Med Genet 2003;40(3):188–91.</mixed-citation></citation-alternatives></ref><ref id="B52"><label>52.</label><citation-alternatives><mixed-citation xml:lang="en">50. Sazonova M., Budnikov E., Khasanova Z. et al. Studies of human aortic intima by a direct quantitative assay of mutant alleles in the mitochondrial genome. Atherosclerosis 2009;204(1):184–90.</mixed-citation><mixed-citation xml:lang="ru">Sazonova M., Budnikov E., Khasanova Z. et al. Studies of human aortic intima by a direct quantitative assay of mutant alleles in the mitochondrial genome. Atherosclerosis 2009;204(1):184–90.</mixed-citation></citation-alternatives></ref><ref id="B53"><label>53.</label><citation-alternatives><mixed-citation xml:lang="en">51. Moraes C.T., Ciacci F., Bonilla E. et al. Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene an etiologic hot spot? J Clin Invest 1993;92(2):2906–15.</mixed-citation><mixed-citation xml:lang="ru">Moraes C.T., Ciacci F., Bonilla E. et al. Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene an etiologic hot spot? J Clin Invest 1993;92(2):2906–15.</mixed-citation></citation-alternatives></ref><ref id="B54"><label>54.</label><citation-alternatives><mixed-citation xml:lang="en">52. Rossmanith W., Karwan R.M. Impairment of tRNA processing by point mutations in mitochondrial tRNA(Leu) (UUR) associated with mitochondrial diseases. FEBS Lett 1998;433(3):269–74.</mixed-citation><mixed-citation xml:lang="ru">Rossmanith W., Karwan R.M. Impairment of tRNA processing by point mutations in mitochondrial tRNA(Leu) (UUR) associated with mitochondrial diseases. FEBS Lett 1998;433(3):269–74.</mixed-citation></citation-alternatives></ref><ref id="B55"><label>55.</label><citation-alternatives><mixed-citation xml:lang="en">53. Mueller E.E., Eder W., Ebner S. et al. The mitochondrial T16189C polymorphism is associated with coronary artery disease in Middle European populations. PLoS One 2011;6(1):e16455.</mixed-citation><mixed-citation xml:lang="ru">Mueller E.E., Eder W., Ebner S. et al. The mitochondrial T16189C polymorphism is associated with coronary artery disease in Middle European populations. PLoS One 2011;6(1):e16455.</mixed-citation></citation-alternatives></ref><ref id="B56"><label>56.</label><citation-alternatives><mixed-citation xml:lang="en">54. Piot C., Croisille P., Staat P. et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008;359(5):473–81.</mixed-citation><mixed-citation xml:lang="ru">Piot C., Croisille P., Staat P. et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008;359(5):473–81.</mixed-citation></citation-alternatives></ref><ref id="B57"><label>57.</label><citation-alternatives><mixed-citation xml:lang="en">55. Mewton N., Croisille P., Gahide G. et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol 2010;55(12):1200–5.</mixed-citation><mixed-citation xml:lang="ru">Mewton N., Croisille P., Gahide G. et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol 2010;55(12):1200–5.</mixed-citation></citation-alternatives></ref><ref id="B58"><label>58.</label><citation-alternatives><mixed-citation xml:lang="en">56. Rudolph V., Rudolph T.K., Schopfer F.J. et al. Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion. Cardiovasc Res 2010;85(1):155–66.</mixed-citation><mixed-citation xml:lang="ru">Rudolph V., Rudolph T.K., Schopfer F.J. et al. Endogenous generation and protective effects of nitro-fatty acids in a murine model of focal cardiac ischaemia and reperfusion. Cardiovasc Res 2010;85(1):155–66.</mixed-citation></citation-alternatives></ref><ref id="B59"><label>59.</label><citation-alternatives><mixed-citation xml:lang="en">57. Shiva S., Sack M.N., Greer J.J. et al. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 2007;204(9):2089–102.</mixed-citation><mixed-citation xml:lang="ru">Shiva S., Sack M.N., Greer J.J. et al. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 2007;204(9):2089–102.</mixed-citation></citation-alternatives></ref><ref id="B60"><label>60.</label><citation-alternatives><mixed-citation xml:lang="en">58. Mureta M., Akao M., O’Rourke B., Marbоn E. Mitochondrial ETP-sensitive potassium channels attenuate matrix Ca(2+) overload during simulated ischemia and reperfusion: possible mechanism of</mixed-citation><mixed-citation xml:lang="ru">Mureta M., Akao M., O’Rourke B., Marbоn E. Mitochondrial ETP-sensitive potassium channels attenuate matrix Ca(2+) overload during simulated ischemia and reperfusion: possible mechanism of</mixed-citation></citation-alternatives></ref><ref id="B61"><label>61.</label><mixed-citation>cardioprotection. Circ Res 2001;89(10):891–8.</mixed-citation></ref><ref id="B62"><label>62.</label><citation-alternatives><mixed-citation xml:lang="en">59. Deja M.A., Malinowski M., Golba K.S. et al. Diazoxide protects myocardial mitochondria, metabolism, and function during cardiac surgery: a double-blind randomized feasibility study of diazoxidesupplemented cardioplegia. J Thorac Cardiovasc Surg 2009;137(4):997–1004.</mixed-citation><mixed-citation xml:lang="ru">Deja M.A., Malinowski M., Golba K.S. et al. Diazoxide protects myocardial mitochondria, metabolism, and function during cardiac surgery: a double-blind randomized feasibility study of diazoxidesupplemented cardioplegia. J Thorac Cardiovasc Surg 2009;137(4):997–1004.</mixed-citation></citation-alternatives></ref><ref id="B63"><label>63.</label><citation-alternatives><mixed-citation xml:lang="en">60. Yusuf S., Dagenais G., Pogue J. et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342(3):154–60.</mixed-citation><mixed-citation xml:lang="ru">Yusuf S., Dagenais G., Pogue J. et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342(3):154–60.</mixed-citation></citation-alternatives></ref><ref id="B64"><label>64.</label><citation-alternatives><mixed-citation xml:lang="en">61. Victor V.M., Rocha M., De la Fuente M. N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radic Res 2003;37(9):919–29.</mixed-citation><mixed-citation xml:lang="ru">Victor V.M., Rocha M., De la Fuente M. N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radic Res 2003;37(9):919–29.</mixed-citation></citation-alternatives></ref><ref id="B65"><label>65.</label><citation-alternatives><mixed-citation xml:lang="en">62. Victor V.M., Rocha M., Esplugues J.V., De la Fuente M. Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 2005;11(24):3141–58.</mixed-citation><mixed-citation xml:lang="ru">Victor V.M., Rocha M., Esplugues J.V., De la Fuente M. Role of free radicals in sepsis: antioxidant therapy. Curr Pharm Des 2005;11(24):3141–58.</mixed-citation></citation-alternatives></ref><ref id="B66"><label>66.</label><citation-alternatives><mixed-citation xml:lang="en">63. Armstrong J.S. Mitochondrial medicine: pharmacological targeting of mitochondria in disease. Br J Pharmacol 2007;151(8):1154–65.</mixed-citation><mixed-citation xml:lang="ru">Armstrong J.S. Mitochondrial medicine: pharmacological targeting of mitochondria in disease. Br J Pharmacol 2007;151(8):1154–65.</mixed-citation></citation-alternatives></ref><ref id="B67"><label>67.</label><citation-alternatives><mixed-citation xml:lang="en">64. Luk T.H., Dai Y.L., Siu C.W. et al. Habitual physical activity is associated with endothelial function and endothelial progenitor cells in patients with stable coronary artery disease. Eur J Cardiovasc Prev Rehabil 2009;16(4):464–71.</mixed-citation><mixed-citation xml:lang="ru">Luk T.H., Dai Y.L., Siu C.W. et al. Habitual physical activity is associated with endothelial function and endothelial progenitor cells in patients with stable coronary artery disease. Eur J Cardiovasc Prev Rehabil 2009;16(4):464–71.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
